← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$1.4M

Shares

7,500

Price

$182

Filed

Apr 23

Insider

Name

Maizel Ari

Title

Chief Commercial Officer

CIK

0002042289

Roles

Officer

Transaction Details

Transaction Date

2026-04-22

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Such transaction was pursuant to a pre-approved 10b5-1 plan. | Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $181.01 and $184.28.

Filing Info

Accession No.

0001193125-26-174415

Form Type

4

Issuer CIK

0001579428

Maizel Ari's History

Date Ticker Type Value
2026-04-22 AXSM M $530K
2026-04-22 AXSM $1.4M
2026-04-22 AXSM M $0
2026-04-21 AXSM A $0
2026-02-26 AXSM A $0
2026-01-21 AXSM M $530K
2026-01-21 AXSM $1.4M
2026-01-21 AXSM M $0

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
2026-04-22